Posts made in April, 2012

The Healthcare Round-Up: 4/20 -4/27

Posted on Friday, April 27, 2012

Last year, Sanofi bought the biotech company Genzyme in a $20.1 billion deal that also included earn-outs tied to the biotech’s promising, albeit risky, multiple sclerosis drug Lemtrada. This week at the 2012...

Learn More

Risk-Sharing: Not Easy, But Impossible To Ignore

Posted on Monday, April 23, 2012

So risk-sharing deals haven’t taken off with the gusto that their compelling logic suggests they should have. Even in Europe — the ripest territory for such contracts, given the alternative may be...

Learn More

The Healthcare Round-Up: 4/14 – 4/21

Posted on Saturday, April 21, 2012

The next big data visualization graphic: This week Express Scripts published its annual drug report. The big news: the cost of nonadherence. Indeed, $317 billion of the $408 billion in pharmacy-related waste...

Learn More

The Healthcare Round-Up: 4/6 – 4/14

Posted on Saturday, April 14, 2012

First ACO’s under Medicare’s Shared Savings Program:  In addition to TEDMED, which this week gathered healthcare luminaries to discuss all things innovative, ACO was the other au courant acronym...

Learn More

England Edges Toward National Cancer Tariff

Posted on Friday, April 6, 2012

April marks the start of an ambitious, if overdue, data collection project in the UK that could ultimately lead to England’s National Health Service paying a series of pre-determined tariffs for cancer...

Learn More

The Healthcare Round-Up: 3/28 – 4/4

Posted on Thursday, April 5, 2012

Reducing unnecessary care: On Wednesday April 4, nine physician societies, together with the ABIM Foundation and Consumer Reports, released a list of 45 procedures or tests (5 per specialty) that are overused...

Learn More